GLUCAGEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glucagen, and when can generic versions of Glucagen launch?
Glucagen is a drug marketed by Novo Nordisk and is included in one NDA.
The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
Summary for GLUCAGEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 15 |
Clinical Trials: | 30 |
Patent Applications: | 134 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GLUCAGEN |
What excipients (inactive ingredients) are in GLUCAGEN? | GLUCAGEN excipients list |
DailyMed Link: | GLUCAGEN at DailyMed |
US Patents and Regulatory Information for GLUCAGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk | GLUCAGEN | glucagon hydrochloride | INJECTABLE;INJECTION | 020918-001 | Jun 22, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |